Q301--Kidney Disease Genetic Panel
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Veterans Affairs (VA), specifically the Richard L. Roudebush VA Medical Center, has issued a Sources Sought Notice for market research purposes. This notice seeks to identify qualified contractors capable of providing reference laboratory testing services for Kidney Disease Genetic Panels, Kidney Transplant Assessments, and Molecular Residual Disease (MRD) Assays. Services are required for VA Medical Centers in Indianapolis, IN, Cleveland, OH, and Cincinnati, OH. Responses are due by March 13, 2026, at 8:30 AM EDT.
Purpose & Scope
This is not a solicitation but a market research effort to gather information for a potential one-time, one-year contract. The VA requires specialized genetic testing services for Chronic Kidney Disease (CKD) patients. The scope includes:
- Kidney Gene Panel Testing: Analysis of over 380 genes using blood or saliva samples.
- Kidney Transplant Assessment: Non-invasive donor-derived cell-free DNA (dd-cfDNA) blood test for organ rejection and tumor evaluation.
- Molecular Residual Disease (MRD) Assay: Custom-designed, personalized tumor-informed assay to detect circulating tumor DNA.
Key Requirements
Contractors must comply with CAP, CLIA, The Joint Commission, NFPA 99, OSHA, HIPAA, and all applicable VA policies. Services include providing necessary supplies for specimen collection, packaging, and paid transportation from VA facilities to the testing laboratory. Results must be transmitted via a secured web-based portal, containing specific patient and test identifiers, and reference ranges. Customer service via a toll-free line is also required.
Contract Details (Intended)
The anticipated contract will be a one-time award with a base year of one (1) year. The applicable NAICS Code is 621511 (Medical Laboratories) with a size standard of $41.5 Million, and the Product Service Code is Q301 (Medical – Reference Laboratory Testing). While no specific set-aside is designated for this Sources Sought, respondents are asked to indicate their business size/type (e.g., SDVOSB, VOSB, 8(a), Small Business, Large Business). SDVOSB/VOSB firms must be registered and certified in the VetCert database.
Submission Requirements
Interested parties must submit their responses via email to Jessica.Bryant5@va.gov by the deadline. The email subject line must include the Sources Sought Notice Number, “Kidney Disease Gene Panel,” and the firm's name. Responses should include completed sections C-G of the provided document, contractor and company information (DUNS, Tax ID, Business Size/Type), relevant attachments, Federal Supply Schedule contract details (if applicable), and an official quote for the specified services and estimated annual quantities.
Additional Notes
All prospective contractors must be registered in the System for Award Management (SAM) at http://www.sam.gov. This notice is for informational and planning purposes only and does not guarantee a future solicitation.